Literature DB >> 8101867

Calcium current block by (-)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl- current.

J M ffrench-Mullen1, J L Barker, M A Rogawski.   

Abstract

Block of a voltage-activated Ca2+ channel current by phenobarbital (PHB), 5-(2-cyclohexylideneethyl)-5-ethyl barbituric acid (CHEB), and the optical R(-)- and S(+)-enantiomers of pentobarbital (PB) was examined in freshly dissociated adult guinea pig hippocampal CA1 neurons; the effects of the barbiturates on GABA-activated Cl- current were also characterized in the same preparation. (-)-PB, PHB, and CHEB produced a reversible, concentration-dependent block of the peak Ca2+ channel current (3 mM Ba2+ as the charge carrier) evoked by depolarization from -80 to -10 mV (IC50 values, 3.5, 72, and 118 microM, respectively). In contrast, (+)-PB was nearly inactive at concentrations up to 1 mM. The inhibitory action of PHB was decreased at acid pH, indicating that the dissociated (anionic) form of the molecule is the active species. Block by (-)-PB was voltage dependent with the fractional block increasing at positive membrane potentials; calculations according to the method of Woodhull indicated that the (-)-PB blocking site senses approximately 40% of the transmembrane electric field. The time course and voltage dependence of activation of the Ca2+ channel current were unaffected by (-)-PB, PHB, and CHEB. The rate of inactivation was enhanced by (-)-PB and CHEB, with the major effect being acceleration of the slow phase of the biexponential decay of the current. GABA-activated Cl- current was potently enhanced by (-)-PB and PHB (EC50 values, 3.4 and 12 microM), whereas (+)-PB was only weakly active. At concentrations of (-)-PB > 100 microM and PHB > 200-300 microM, Cl- current responses were activated even in the absence of GABA. These results demonstrate that in CA1 hippocampal neurons, PB causes a stereoselective block of a voltage-activated Ca2+ current; PHB is also effective, but at higher concentrations. For (-)-PB, the effect on Ca2+ channel current occurred at similar concentrations as potentiation of GABA responses. In contrast, PHB was more potent as a GABA enhancer than as blocker of Ca2+ current, but the maximal potentiation of GABA responses was 40% of that obtained with (-)-PB. Consequently, the anticonvulsant action of PHB at clinically relevant concentrations may relate to modest enhancement of GABA responses and partial blockade of Ca2+ current, whereas the sedative effects that occur at higher concentrations could reflect stronger Ca2+ current blockade. The powerful sedative-hypnotic action of (-)-PB may reflect greater maximal enhancement of GABA responses in conjunction with strong inhibition of Ca2+ current.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101867      PMCID: PMC6576525     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  20 in total

1.  Activation and block of recombinant GABA(A) receptors by pentobarbitone: a single-channel study.

Authors:  G Akk; J H Steinbach
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

3.  Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.

Authors:  J M Rho; S D Donevan; M A Rogawski
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

4.  Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor.

Authors:  D J Cordato; M Chebib; L E Mather; G K Herkes; G A Johnston
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Pentobarbital inhibition of human recombinant alpha1A P/Q-type voltage-gated calcium channels involves slow, open channel block.

Authors:  A Schober; E Sokolova; K J Gingrich
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Inhibition of recombinant L-type voltage-gated calcium channels by positive allosteric modulators of GABAA receptors.

Authors:  Damien E Earl; Elizabeth I Tietz
Journal:  J Pharmacol Exp Ther       Date:  2011-01-24       Impact factor: 4.030

7.  Electrophysiological and metabolic effects of a convulsant barbiturate on dissociated mouse primary sensory neurons.

Authors:  R J Pearce; M R Duchen
Journal:  J Physiol       Date:  1995-03-01       Impact factor: 5.182

8.  Selective GABA-receptor actions of amobarbital on thalamic neurons.

Authors:  H-S Kim; X Wan; D A Mathers; E Puil
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

9.  Altered pharmacology and GABA-A receptor subunit expression in dorsal midline thalamic neurons in limbic epilepsy.

Authors:  Karthik Rajasekaran; Chengsan Sun; Edward H Bertram
Journal:  Neurobiol Dis       Date:  2008-10-17       Impact factor: 5.996

10.  Effects of general anesthetics on substance P release and c-Fos expression in the spinal dorsal horn.

Authors:  Toshifumi Takasusuki; Shigeki Yamaguchi; Shinsuke Hamaguchi; Tony L Yaksh
Journal:  Anesthesiology       Date:  2013-08       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.